Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Autor:
Dong Wook Shin, Jong Ho Cho, Su Min Jeong, Dong Woog Yoon, Sang Hyun Park, Jeong Hoon Yang, Kyungdo Han
Publikováno v:
Lung Cancer. 136:115-121
Objectives With advances in lung cancer treatments, the number of lung cancer survivors has increased. As cardiovascular diseases (CVD) are some of the major causes of non-cancer deaths, CVD management is an integral part of cancer survivorship care.
Autor:
Jong Mu Sun, Se-Hoon Lee, Hansang Lee, Keunchil Park, Hee Kyung Kim, Sung-min Kim, Jang Ho Cho, Sung Won Lim, Myung-Ju Ahn, Jin Seok Ahn, Song Ee Park, Youjin Kim, Sehhoon Park
Publikováno v:
Lung Cancer. 124:293-297
Objectives Several studies have demonstrated the promise of continuation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) beyond progression in patients with EGFR-mutant non-small-cell lung cancer (NSCLC). The aim of the pre
Autor:
Kyuichi Kadota, Kenichiro Sakai, Hiroshi Miyawaki, Nobuyuki Kita, Nobuhiro Kanaji, Naoki Watanabe, Norimitsu Kadowaki, Yutaka Ueda, Shuji Bandoh, Tomoya Ishii
Publikováno v:
Lung Cancer. 108:126-133
Objectives Small cell lung cancer (SCLC) can be subgrouped into central and peripheral types according to the location of the primary lesion. However, the clinical differences between these two types remain unclear. This study compared their clinical
Autor:
Brian M. Alexander, Nancy E. Pinnell, Raymond H. Mak, David M. Jackman, Laura W. Christianson, Phillip J. Gray, Beow Y. Yeap, Elizabeth H. Baldini, Nils D. Arvold, Aileen B. Chen, David J. Sher, David Kozono, Scott J. Swanson, Sarah K Cryer
Publikováno v:
Lung Cancer. 85:239-244
Optimal therapy for patients with non-small cell lung carcinoma (NSCLC) presenting with synchronous brain-only oligometastases (SBO) is not well defined. We sought to analyze the effect of differing therapeutic paradigms in this subpopulation.We retr
Autor:
Keith Sigel, Grace Mhango, Juan P. Wisnivesky, Marcelo Bonomi, Cara Bergamo, Minal Kale, Linda Lurslurchachai, Ethan A. Halm
Publikováno v:
Lung Cancer. 82:266-270
Chemoradiotherapy is the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). Elderly patients, who are often considered unfit for combined chemoradiotherapy, frequently receive radiation therapy (RT) alone. Using populatio
Autor:
Yuzo Hasegawa, T. Sakaida, Toshihiko Iizasa, O. Nagano, Sana Yokoi, Hajime Kageyama, K. Kawasaki, Masato Shingyoji, Kazuo Hatano, Meiji Itakura, Toshihiko Iuchi
Publikováno v:
Lung Cancer. 82:282-287
Background Brain metastases (BM) are a common in patients with lung cancer. Although whole-brain radiation therapy (WBRT) is the standard therapy, it may have a risk of decline in cognitive function of patients. In this study, we evaluated the effica
Autor:
Akira Ono, Asuka Tsuya, Toshiaki Takahashi, Kazuhisa Takahashi, Hideyuki Harada, Yoko Nakasu, Rieko Kaira, Yukiko Nakamura, Nobuyuki Yamamoto, Masahiro Endo, Hirotsugu Kenmotsu, Koichi Mitsuya, Takehito Shukuya, Tateaki Naito, Haruyasu Murakami
Publikováno v:
Lung Cancer. 74:457-461
Introduction Based on previous reports, patients who experience isolated central nervous system (CNS) failure may not have systemic acquired resistance to EGFR-TKI therapy. However, because there are few articles that have reported on the clinical ef
Autor:
Kazuhiko Nakagawa, Koshiro Watanabe, Nobuyuki Yamamoto, Hiroaki Okamoto, Isamu Okamoto, Toshiaki Takahashi, Kiyoshi Nakamatsu, Masahiro Fukuoka, Yasumasa Nishimura
Publikováno v:
Lung Cancer. 72:199-204
Introduction: A feasibility study was performed to examine the safety and toxicity profile of daily gefitinib (250 mg) administration with concurrent definitive thoracic radiation therapy (TRT) in patients with unresectable non-small cell lung cancer
Autor:
Toshio Sugane, Jun-etsu Mizoe, Kyousan Yoshikawa, Naoyoshi Yamamoto, Tadashi Kamada, Susumu Kandatsu, Hirohiko Tsujii, Masayuki Baba, Reiko Imai, Tadaaki Miyamoto, Hidefumi Ezawa, Mio Nakajima
Publikováno v:
Lung Cancer. 64:45-50
Surgical resection is the standard treatment for stage I non-small cell lung cancer (NSCLC). However, elderly patients with NSCLC often suffer from other conditions, such as chronic obstructive pulmonary disease (COPD) or cardiovascular disease, and
Publikováno v:
Lung Cancer. 63:393-399
The purpose of this study was to evaluate the efficacy of oral glutamine in the prevention of acute radiation-induced esophagitis (ARIE) and weight loss in lung carcinoma patients, and to determine the clinical/dosimetric predictors of ARIE.Data from